Neurodermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the above diagnostic criteria of Traditional Chinese and western medicine; ? (2) Patients aged 18-65 years, with no gender limitation, and the course of disease =6 weeks; ? (3) The total skin area shall not exceed 10% of the body surface; (4) Pruritus peak value scale (PP-NRS)=4; (5) Clear mind, able to understand the scale content and cooperate with treatment, willing to participate in this study, and sign informed consent. Only those who meet the above five criteria can be included in the study.
Exclusion criteria
Exclusion criteria: (1) patients who have used glucocorticoids and calcineurin inhibitors within and outside 2 weeks; (2) oral glucocorticoids and antihistamines within 2 weeks; (3) patients with serious diseases of heart, lung, brain, liver, kidney and hematopoietic system, mental diseases and cognitive dysfunction; (4) women who plan to become pregnant during pregnancy, lactation or within the last 8 months; (5) skin lesions on the face and eyelids; (6) scar constitution; (7) Infection, damage and erosion at the lesion; (8) Allergy, contraindication or intolerance to halometasone ointment; (9) Those who refuse to take hormone drug treatment or refuse to accept fire needle treatment. Those who met any one of the above criteria were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PeakPruritus Numerical Rating Scale; | — |
Countries
China